BEDFORD, Mass.--(BUSINESS WIRE)--Avila Therapeutics, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced today that Katrine Bosley, Avila’s CEO, is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference at 2:30 p.m. PT on Monday, January 9, 2012, at the Westin St. Francis, San Francisco.
